12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

• Forte Biosciences FBRX shares increased by 11.8% to $0.5 during Friday's after-market session. Today's trading volume for this security ended up closing at 287.3K shares, which is 905.6 percent of its average volume over the last 100 days. The company's market cap stands at $18.1 million. As per the news, the Q3 earnings report came out 4 days ago.
• Telesis Bio TBIO shares rose 10.81% to $0.41. Today's trading volume for this security ended up closing at 481.1K shares, which is 1248.9 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $12.2 million. As per the press release, Q3 earnings came out 4 days ago.
• AcelRx Pharmaceuticals ACRX stock moved upwards by 8.16% to $0.53. The company's market cap stands at $8.8 million.
• DermTech DMTK stock increased by 7.33% to $1.61. The market value of their outstanding shares is at $55.1 million.
• Renalytix RNLX stock rose 7.04% to $0.59. The market value of their outstanding shares is at $28.9 million. As per the press release, Q1 earnings came out 3 days ago.
• IN8bio INAB shares increased by 6.0% to $0.96. The market value of their outstanding shares is at $30.7 million.

Losers

• Nautilus Biotechnology NAUT stock declined by 10.5% to $2.71 during Friday's after-market session. The market value of their outstanding shares is at $338.8 million.
• OpGen OPGN stock decreased by 9.83% to $0.41. The market value of their outstanding shares is at $4.5 million. The company's, Q3 earnings came out 3 days ago.
• Bone Biologics BBLG stock decreased by 9.76% to $0.55. Trading volume for this security closed at 544.9K, accounting for 54.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.7 million. The company's, Q3 earnings came out 3 days ago.
• ProSomnus OSA stock declined by 8.03% to $0.46. The company's market cap stands at $7.5 million.
• Kintara Therapeutics KTRA shares declined by 7.63% to $0.34. As per the press release, Q1 earnings came out 4 days ago.
• Altamira Therapeutics CYTO stock fell 7.15% to $0.26. Today's trading volume for this security ended up closing at 14.6 million shares, which is 1359.1 percent of its average volume over the last 100 days. The company's market cap stands at $2.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.